IFNA1 and neuromuscular disease: In our previous study, both biomarkers were low in healthy controls and non-inflammatory neuromuscular disease, but elevated in SLE and adult myositis, suggesting high sensitivity for detecting IFN-driven inflammation but limited disease specificity for JDM [21].